Article Details

Q32 Bio Appoints Experienced Biopharmaceutical Leader Mark Iwicki as Chairman of Board of ...

Retrieved on: 2020-12-22 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Q32 Bio Appoints Experienced Biopharmaceutical Leader Mark Iwicki as Chairman of Board of .... View article details on hiswai:

Excerpt

Q32 Bio's lead program for innate immunity, ADX-097, is based on a pioneering approach enabling tissue-targeted regulation of the complement system ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up